H. Lundbeck A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT06004180
- Locations
- 🇯🇵
Ehime University Hospital, Ehime, Japan
A Study Investigating Lu AG06474 in Healthy Young Participants
- First Posted Date
- 2023-07-13
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 56
- Registration Number
- NCT05943327
- Locations
- 🇺🇸
Quotient Sciences Miami, Miami, Florida, United States
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 315
- Registration Number
- NCT05897320
- Locations
- 🇪🇸
Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
🇹🇷Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Fatih/Istanbul, Turkey
🇪🇸Hospital Clinico San Carlos, Madrid, Spain
Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 12
- Registration Number
- NCT05669950
- Locations
- 🇬🇧
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
🇸🇪Karolinska University Hospital/ Huddinge, Huddinge, Sweden
🇸🇪Sahlgrenska University Hospital, Gothenburg, Sweden
Observational Study in Multiple System Atrophy
- Conditions
- Multiple System Atrophy
- Interventions
- Diagnostic Test: plasma NfL and brain MRI (vMRI, DTI, and ASL [if feasible]) only for the EU cohort
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 90
- Registration Number
- NCT05453058
- Locations
- 🇨🇳
The Second Affiliated Hospital of Soochow University, Suzhou, China
🇨🇳Beijing Tiantan Hospital, Capital Medical University, Beijing, China
🇨🇳Beijing Xuanwu Hospital, Capital Medical University, Beijing, China
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
- Conditions
- Medication Overuse HeadacheMigraine
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 570
- Registration Number
- NCT05452239
- Locations
- 🇪🇸
Hospital Universitario Virgen del Rocio - PPDS, Sevilla, Spain
🇪🇸Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
🇦🇺Alfred Health, Melbourne, Victoria, Australia
A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT05320302
- Locations
- 🇬🇧
Invicro, London, United Kingdom
A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 8
- Registration Number
- NCT05306366
- Locations
- 🇸🇪
Karolinska Trial Alliance, Huddinge, Sweden
A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 52
- Registration Number
- NCT05304910
- Locations
- 🇺🇸
PAREXEL International, Glendale, California, United States
Real World Effectiveness of Eptinezumab in Participants With Migraine
- Conditions
- Migraine
- Interventions
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 32
- Registration Number
- NCT05284019
- Locations
- 🇺🇸
Gilbert Neurology Partners/ CCT Research, Gilbert, Arizona, United States
🇺🇸Ki Clinical Research LLC, dba New England Institute for Clinical Research, Stamford, Connecticut, United States
🇺🇸Innovation Medical Group, Palmetto Bay, Florida, United States